Breaking News, Financial News

Financial Report: Merck 4Q

Worldwide sales of Singulair were $1.3 billion in the quarter (+12%), and for the year sales were $4.7 billion (+7%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Merck 4Q 4Q Revenues: $10.1 billion (+67%) 4Q Earnings: $6.5 billion (earnings were $1.6 billion in 4Q08) FY Revenues: $27.4 billion (+15%) FY Earnings: $12.9 billion (+65%) Comments: Worldwide sales of Singulair were $1.3 billion in the quarter (+12%), and for the year sales were $4.7 billion (+7%). Global sales of Zetia and Vytorin were $614 million and $577 million in the quarter, respectively, and for the year were $2.2 billion and $2.1 billion, respectively. The Merck/Scherin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters